#USA #New York #Class Action #Levi Korsinsky #Zynex Inc

Important Update for Zynex, Inc. Shareholders

Levi & Korsinsky, LLP is reaching out to investors in Zynex, Inc. (traded as OTC PINK: ZYXIQ) regarding a significant development in a class action securities lawsuit that impacts the company’s shareholders.

What is Happening?

The legal firm has notified Zynex, Inc. investors that there is a deadline approaching for them to act as lead plaintiffs in this lawsuit. The date to remember is April 21, 2026. This class action aims to seek recoveries for investors who were negatively impacted by alleged securities fraud committed by the company between February 25, 2021, and December 15, 2025.

Class Action Overview

The lawsuit claims that Zynex made several misleading statements that obscured the true nature of its business practices. Among the key allegations are that Zynex oversupplied products, which inflated its revenue figures. This practice not only violated several industry regulations but also drew scrutiny from various insurers, including the health insurance program, Tricare. Particularly concerning is the suit filed by Travelers on August 21, 2023, which accuses Zynex and key insiders of engaging in a fraudulent overbilling scheme that seeks damages exceeding $23 million.

Defendants and Allegations

The complaint outlines a pattern of behavior characterized by not only an aggressive sales strategy but also a reckless disregard for compliance with industry laws. Key issues raised include:

• - The issuance of false claims to enhance revenue figures.
• - A lack of commitment from the management towards establishing strong internal controls.
• - Growth in product orders was deemed illegal due to overbilling practices.

As a result of these actions, there is a genuine risk of Zynex facing severe penalties, including potential removal from insurer networks.

Company insiders allegedly participated in enhancing the stock price through stock repurchase plans, even acquiring millions of dollars in stocks directly, which misleads the investing public about the company’s actual market value.

What Should Investors Do?

Investors who experienced losses during the specified timeframe are encouraged to reach out if they wish to claim their rights. The deadline to apply for lead plaintiff status is April 21, 2026, but participating in any potential recovery does not necessitate being a lead plaintiff.

No Cost to You

Notably, for those involved in the class action, there are no out-of-pocket costs or fees associated with participation. Levi & Korsinsky reassures potential claimants that their engagement does not entail any financial obligation.

Why Choose Levi & Korsinsky?

Levi & Korsinsky, with over two decades of experience, has successfully retrieved hundreds of millions for aggrieved shareholders. The firm is recognized for its versatility in complex securities litigation, bolstered by a robust team of 70 professionals dedicated to serving clients. It has consistently ranked as one of the top securities litigation firms across the United States in the ISS Securities Class Action Services’ Top 50 Report.

Contact Information

Shareholders seeking further information or wishing to participate in the class action can reach out to Joseph E. Levi, Esq. or Ed Korsinsky, Esq. at Levi & Korsinsky, located at:
33 Whitehall Street, 27th Floor
New York, NY 10004

For inquiries, you may contact them at (212) 363-7500, or email email protected]. Additional details can be found through their website, [zlk.com.

Stay informed and protect your rights as an investor. The actions you take today could secure your holdings tomorrow.